EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maternal vaccination protects dams and prevents in utero transmission of Rift Valley fever virus in rats

Austin T Hertel iD, Cynthia M McMillen iD, Ryan M Hoehl, Zachary D Frey, Anita K McElroy iD, Amy L Hartman iD

mBio · 12.08.2026 · 17 (8)

DOI: 10.1128/mbio.00253-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 12.08.2026. Verfasst von Austin T Hertel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Rift Valley Fever, Rift Valley fever virus, Viral Vaccines, Infectious Disease Transmission, Vertical. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In utero transmission and spontaneous fetal death are hallmarks of Rift Valley fever virus (RVFV) infection in pregnant animals. Compounding evidence indicates pregnant individuals are particularly vulnerable to RVFV, as in utero transmission and increased rates of miscarriage have been reported in people infected during pregnancy. Further, human placenta explants are permissive to RVFV infection. Viable vaccine candidates intended for veterinary or human use must protect vulnerable populations, including pregnant individuals and fetuses. Using a pregnant rat model, we show that maternal vaccination with a live-attenuated RVFV lacking the non-structural proteins NSs and NSm (RVFV-delNSs/NSm) is immunogenic, safe, and protective. Dams vaccinated either prior to or during pregnancy were protected from virulent challenge during pregnancy, and we found no evidence of infectious virus in the placentas and fetuses of challenged animals. These studies offer important pre-clinical data in a tractable pregnancy model and serve as a blueprint for evaluating future vaccine approaches designed to protect pregnant individuals and their fetuses. IMPORTANCE Rift Valley fever virus (RVFV) poses a formidable threat to pregnant animals and potentially to pregnant individuals and their developing fetuses. Despite this risk, pregnant individuals are rarely included in vaccine trials, leaving this potentially vulnerable population unprotected. Using a live-attenuated RVFV vaccine, we demonstrate that maternal vaccination is safe and protects both pregnant rats and their fetuses from congenital Rift Valley fever. Because live-attenuated vaccines are often contraindicated during pregnancy due to theoretical safety concerns, we further show that vaccination prior to pregnancy provides equivalent protection throughout future pregnancy. Taken together, these findings provide a blueprint for the preclinical evaluation of RVFV vaccines during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rift Valley FeverRift Valley fever virusViral VaccinesInfectious Disease Transmission, VerticalVaccinationAnimalsFemalePregnancyRatsVaccines, AttenuatedDisease Models, AnimalPlacentaAntibodies, Viral

Stichwörter der Autor:innen

RNA virusRift Valley feverbunyaviruspregnancyvaccinevertical transmission

Substanzen

Viral VaccinesVaccines, AttenuatedAntibodies, Viral

Autor:innen und Institutionen

  • Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Infectious Disease and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Division of Pediatric Infectious Disease, Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Austin T Hertel, Cynthia M McMillen, Anita K McElroy, Amy L Hartman

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hertel, A. T., McMillen, C. M., Hoehl, R. M., Frey, Z. D., McElroy, A. K., & Hartman, A. L. (2026). Maternal vaccination protects dams and prevents in utero transmission of Rift Valley fever virus in rats. mBio, 17(8). https://doi.org/10.1128/mbio.00253-26

Vancouver

Hertel AT, McMillen CM, Hoehl RM, Frey ZD, McElroy AK, Hartman AL. Maternal vaccination protects dams and prevents in utero transmission of Rift Valley fever virus in rats. mBio. 2026;17(8). doi:10.1128/mbio.00253-26

BibTeX
@article{Hertel2026,
  author = {Hertel, Austin T and McMillen, Cynthia M and Hoehl, Ryan M and Frey, Zachary D and McElroy, Anita K and Hartman, Amy L},
  title = {Maternal vaccination protects dams and prevents in utero transmission of Rift Valley fever virus in rats},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {8},
  doi = {10.1128/mbio.00253-26}
}
Kostenlos starten →